Growing prevalence of cardiovascular diseases is expected to drive the growth of India valsartan market.
According to TechSci Research report, “India Valsartan Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Solution, Others), By Distribution Channel (Online v/s Offline), By Application (Hypertension, Heart Failure, Myocardial Infarction, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026”, the India valsartan market is expected to grow at a formidable rate during the forecast period on account of the changing lifestyle patterns, lack of physical exercises, intake of junk food and improper dietary habits. This has led to increasing incidences of obesity, diabetes, cardiovascular diseases, among others. This in turn is expected to positively influence the market growth over the next few years. Additionally, valsartan is widely used in the treatment of diabetic neuropathy. This in tun is expected to positively influence the market growth through FY2026. However, side effects such as headache, nausea, diarrhea, stomach pain, among others associated with valsartan can restrict the market growth during the forecast period. Moreover, severe side effects such as difficulty in breathing or swallowing, unexplained weight gain, among others can further hamper the market growth over the next few years.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on“ India Valsartan Market “
The India valsartan market is segmented based on source, form, distribution channel, application, end user, company and region. Based on form, the market can be categorized into tablet, capsule, solution and others. The tablet segment is expected to dominate the market since it can accommodate a large amount of API as compared to the other counterparts. While capsule segment is expected to register the highest growth during the forecast period on account of the associated benefits such as fast action, tamper resistance, higher rate of absorption, among others. Based on distribution channel, the market can be split into online and offline. The offline channel is expected to dominate the market owing to the consumer preference for buying medicines from a pharmacy or drug store. The online segment is also expected to register significant growth over the next few years. This can be ascribed to the emergence of several online pharmacies, digital platforms and mobile applications and doorstep drug delivery e-commerce platforms in the country.
Jubilant Pharma Ltd., Aurobindo Pharma Ltd., Sun Pharmaceuticals Industries Ltd., Amneal Pharmaceuticals Pvt. Ltd., Torrent Pharmaceutical Ltd., Unichem Laboratories Ltd., Novartis India Ltd., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceuticals Industries Ltd., Lupin Pharmaceuticals Ltd. and others are some of the leading players operating in India valsartan market. Companies operating in the market are using organic strategies such as product launches, portfolio expansions, customer focus approach, mergers and collaborations to boost their share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5155
Customers can also request for 10% free customization on this report.
“India valsartan market is expected to witness growth during the forecast period on account of the growing incidences of cardiac arrests, strokes, among others. Additionally, the drug is highly effective in treating hypertension thereby driving the market growth over the next few years. Furthermore, supportive government policies and schemes launched by the government of India such as incentive linked production scheme, establishment of bulk drug parks, among others.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based India management consulting firm.
“India Valsartan Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Solution, Others), By Distribution Channel (Online v/s Offline), By Application (Hypertension, Heart Failure, Myocardial Infarction, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India valsartan market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in India valsartan market.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017